Anteris Technologies Global Corp. Share Price
AVRAnteris Technologies Global Corp. Stock Performance
Open $5.29 | Prev. Close $5.42 | Circuit Range N/A |
Day Range $5.13 - $5.50 | Year Range $2.35 - $8.79 | Volume 39,706 |
Average Traded $5.28 |
Anteris Technologies Global Corp. Share Price Chart
About Anteris Technologies Global Corp.
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Anteris Technologies Global Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $5.29 | $5.50 | +4.87% |
05-Feb-26 | $5.52 | $5.24 | -5.76% |
04-Feb-26 | $5.96 | $5.56 | -5.92% |
03-Feb-26 | $6.11 | $5.91 | -3.82% |
02-Feb-26 | $5.96 | $6.14 | +3.10% |
30-Jan-26 | $6.23 | $5.96 | -4.64% |
29-Jan-26 | $6.30 | $6.25 | -1.50% |